TALLINN - Estonia's position in the chemicals and pharmaceuticals industry fell from fourth to seventh place among all 20 regional markets surveyed, according to BMI's Business Environment Ranking matrix for this year's second quarter. This still places it above its Baltic neighbors, Latvia and Lithuania. While Estonia's overall pharmaceutical score remained virtually unchanged from the previous quarter, and above average for the region, the country's attractiveness is severely constrained by its small population, high out-of-pocket expenditures on drugs, which is threatened by the curr...
The article you requested can be accessed only by subscribing to the online version of The Baltic Times. If you are already subscribed to The Baltic Times, please authorize yourself.
In case you don't have a subscription yet - please visit our
SUBSCRIPTION section
